Mankind Pharma's bold bet: Game-changer or gamble?

Weekly Our top insights on funds, personal finance and stocks this week --------------------------------------------------------------- 11-Oct-2024 --------------------------------------------------------------- [story-image]( Stockwire [Mankind Pharma's Rs 10,000 crore debt bet on Bharat Serums: Masterstroke or risky gamble?]( [We examine whether the new acquisition stands to be a game-changer or a disaster]( --------------------------------------------------------------- [story-image]( New Issue Announcements [Momentum meets fundamentals | Wealth Insight's October issue is out now!]( [Discover the highlights of our latest edition]( --------------------------------------------------------------- [story-image]( ABCD ETF [Thematic investing with passive ETFs]( [Siddharth Srivastava, Head of ETF Products at Mirae Asset Investment Managers, shares insight on thematic passive investing]( --------------------------------------------------------------- [story-image]( Stockwire [5 high-growth stocks that turned attractive the past week]( [Our high-rated stocks that have turned cheaper recently]( --------------------------------------------------------------- [story-image]( Newswire [RBI holds rates steady at 6.50 per cent; fund managers suggest where to invest]( [Although the rates remain unchanged, RBI's shift to 'neutral' stance indicates potential cuts]( --------------------------------------------------------------- [story-image]( First Page [Bags of money]( [Treating your savings and investments as one big lump of money is not the best way to prepare for the future]( --------------------------------------------------------------- [story-image]( Stockwire [Why is D-Street's love for D-Mart fading?]( [We explore why the retail giant is falling out of the market's favour]( --------------------------------------------------------------- [story-image]( Learning [Should you invest a lump sum in aggressive hybrid funds?]( [Understanding why a staggered investment in mutual funds offers an advantage]( --------------------------------------------------------------- [story-image]( Words Worth [How Havells India escaped its deathly cash trap in early 2000s]( [A look into Havells' innovative financial re-engineering that elevated its cash flow woes]( --------------------------------------------------------------- [story-image]( [New Issue Announcement]( [Best Funds for 2024]( [Handpicked mutual funds to build a winning portfolio. Order now!]( --------------------------------------------------------------- More from Value Research [Editor's Note]( [Editor's Note]( [Dhirendra Kumar’s insights and timeless advice for investors]( Was this email forwarded to you? [Sign up here]( [vro-logo]( [value research app]( Copyright © Value Research India Private Limited 2024. All rights reserved. C-103, Sector 65 Noida, 201301. This notification mail has been sent to you at {EMAIL} because you are a member of Value Research Online. [Manage Newsletters]( [Unsubscribe]( [Privacy Policy]( Follow us: [twitter-icon]( [facebook-icon]( [youtube-icon]( [linkedIn-icon]( [instagram-icon](